跳至主要内容
临床试验/NCT03727711
NCT03727711Unknown不适用

"Transcutaneous Tibial Nerve Stimulation as a Conservative Treatment for Overactive Bladder Dysfunction -A Randomised Controlled Trial Comparing Home Versus Hospital Based Treatment"

NHS Greater Glasgow and Clyde2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年9月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
80
试验地点
2
主要终点
Change in the International Consultation of Incontinence Modular - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) Long Form Questionnaire total score

研究概览

简要总结

Comparison of home versus hospital Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS). TPTNS has been shown to be an effective treatment of overactive bladder in hospital. We aim to see if this effect is replicated at home.

80 patients will be recruited, 40 into each arm.

Inclusion criteria:

  1. Women aged ≥18 years
  2. Clinical diagnosis of Overactive Bladder (OAB)
  3. Post-void residual urine volume of < 100ml
  4. Able to do questionnaires
  5. Able to consent and willing to participate

Exclusion Criteria

  1. Cardiac pacemaker in situ
  2. Leg ulcer/skin condition affecting both lower legs
  3. Diagnosed peripheral vascular disease
  4. Absent sensation at the electrode site
  5. Current Urinary Tract Infection (UTI) - must be treated with appropriate antibiotics as per the unit protocol prior to commencing study
  6. Pregnancy
  7. Previous Percutaneous Tibial Nerve Stimulation (PTNS) /Sacral Nerve Stimulation (SNS) course
  8. Previous intravesical botox treatment
  9. Unable to complete questionnaires

TPTNS will be taught to the home group and delivered to the participants in the hospital group in individual appointments: 12 treatment sessions of 30 minutes duration, delivered twice weekly over a 6 week period. Two surface electrodes are applied to the right ankle. These electrodes are attached to an electrical stimulator, programmed to safely deliver electric pulses.

On completion of 6 sessions, all participants will be contacted and asked to do a Patient Global Impression of Improvement Scale (PGIIS) and Patient Perception of Bladder Condition (PPBC). After 12 sessions (the final treatment session) all participants will be reviewed by the investigators in the hospital and the outcome measures repeated. Participants receiving home treatment will be posted out a 3 day bladder diary to complete. At this point the participants receiving home treatment will return the machine. All participants will complete and return a 72-hour bladder diary and validated questionnaires routinely used at the study centre to measure lower urinary tract symptoms - The International Consultation of Incontinence Modular Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) long form, the International Consultation of Incontinence Modular Questionnaire - Urinary Incontinence questionnaire (ICIQ-UI short-form. The Hospital Anxiety and Depression Scale (HADS) and the European Quality of Life - 5D Questionnaire (EQ-5D) will also be measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged greater than or equal to 18 years
  • Clinical diagnosis of OAB
  • Post-void residual urine volume of < 100ml
  • Able to do questionnaires
  • Able to consent and willing to participate

排除标准

  • Cardiac pacemaker in situ
  • Leg ulcer/skin condition affecting both lower legs
  • Diagnosed peripheral vascular disease
  • Absent sensation at the electrode site
  • Current UTI - must be treated with appropriate antibiotics as per the unit protocol prior to commencing study
  • Previous PTNS /SNS
  • Previous intravesical botox treatment
  • Unable to complete questionnaires

研究组 & 干预措施

Home Treatment

Experimental

Participants will be taught home treatment with TPTNS - twice weekly, 30 minute sessions for 6 weeks

干预措施: TPTNS (Other)

Hospital Treatment

Active Comparator

Participants will receive hospital treatment with TPTNS - twice weekly, 30 minute sessions for 6 weeks

干预措施: TPTNS (Other)

结局指标

主要结局

Change in the International Consultation of Incontinence Modular - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) Long Form Questionnaire total score

时间窗: At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment)

The ICIQ-FLUTS Long Form is a patient-completed questionnaire for evaluating female lower urinary tract symptoms and impact on quality of life (QoL) - 18 questionnaire items are asked and summed to calculate total score. Total score range (0-69) - a higher score indicates a worse outcome. Bother scales are not incorporated in the overall score but indicate impact of individual symptoms for the patient .

次要结局

  • PGIS (Patient Global Impression of Improvement Scale) Score(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in HADS (Hospital Anxiety and Depression) scores(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in number of urgency incontinence episodes recorded on 72 hour bladder diary.(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in individual urgency score on International Consultation of Incontinence Modular Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) Long Form Questionnaire(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in individual frequency score on International Consultation of Incontinence Modular Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ - FLUTS) Long Form Questionnaire(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in individual nocturia score on International Consultation of Incontinence Modular Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ - FLUTS) Long Form Questionnaire(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in incontinence symptom severity(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))
  • Change in Mean urgency perception scores recorded on 72 hour bladder diary •(At 6 weeks (i.e. after the last TPTNS treatment) and at 12 weeks (i.e. 6 weeks after last the TPTNS treatment))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验